Savara INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
SVRA
Savara INCFrazier Life Sciences entities and individuals have filed an amended Schedule 13G, detailing their beneficial ownership in Savara Inc. common stock.
NASDAQ
SVRA
Savara INCNantahala Capital Management, LLC and its managing members reported a 3.61% beneficial ownership stake in Savara Inc. common stock as of December 31, 2025.
NASDAQ
SVRA
Savara INCFarallon Capital Management updates its Schedule 13G filing for Savara Inc., detailing changes in beneficial ownership and internal management personnel.
NASDAQ
SVRA
Savara INCBlackRock, Inc. has reported a 5.4% beneficial ownership stake in Savara Inc.'s common stock as of December 31, 2025.
NASDAQ
SVRA
Savara INCA group of Venrock entities and individuals has reported a 7.3% beneficial ownership stake in Savara Inc. as of September 30, 2025.
NASDAQ
SVRA
Savara INCSCHEDULE 13G: Nantahala Capital Discloses 5.08% Stake in Savara Inc.
Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, reported beneficial ownership of 5.08% of Savara Inc.'s common stock as of September 30, 2025.
NASDAQ
SVRA
Savara INCSCHEDULE 13G/A: Vestal Point Capital Reduces Savara Inc Stake to 2.3%
Vestal Point Capital and Ryan Wilder have reported a beneficial ownership of 2.3% in Savara Inc, holding 4,015,000 shares as of September 30, 2025.
NASDAQ
SVRA
Savara INCDeerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have jointly reported a beneficial ownership of 6.74% in Savara Inc. common stock.
NASDAQ
SVRA
Savara INCSCHEDULE 13G/A: BlackRock Adjusts Savara Inc. Stake to 4.8%
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.8% beneficial ownership stake in Savara Inc.'s common stock as of September 30, 2025.
NASDAQ
SVRA
Savara INCFrazier Life Sciences and affiliated entities filed an amended Schedule 13G, clarifying their beneficial ownership of Savara Inc. common stock.
NASDAQ
SVRA
Savara INCA group of Venrock-affiliated entities and individuals have disclosed a collective beneficial ownership of 5.2% of Savara Inc.'s common stock, totaling 9,021,507 shares.
NASDAQ
SVRA
Savara INCFrazier Life Sciences and affiliated entities have filed an amended Schedule 13G, disclosing a combined beneficial ownership of 6.6% in Savara Inc. Common Stock as of March 31, 2025.
NASDAQ
SVRA
Savara INCVestal Point Capital, LP and Ryan Wilder have disclosed a passive 6.3% beneficial ownership stake in Savara Inc., holding 10,775,000 shares of common stock.
NASDAQ
SVRA
Savara INCSCHEDULE 13G/A: Farallon Capital Management Discloses 9.99% Stake in Savara Inc. Through Various Funds and Warrants
Farallon Capital Management and its affiliated entities have disclosed a combined beneficial ownership of 9.99% in Savara Inc.'s common stock, including shares held directly and those exercisable through warrants, as of December 31, 2024.
NASDAQ
SVRA
Savara INCSCHEDULE 13G/A: Wellington Management Group Amends Stake in Savara Inc.
Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, disclosing a beneficial ownership of 3.19% in Savara Inc. common stock as of December 31, 2024.